Robert Glanzman
-
- Multiple Sclerosis Research Studies 6
- Neurology top 5%
- Amyotrophic Lateral Sclerosis Research 3
- Peripheral Neuropathies and Disorders 2
- Botulinum Toxin and Related Neurological Disorders 2
- Parkinson's Disease Mechanisms and Treatments 2
- Immunology top 10%
- Physiology top 10%
-
- Polyomavirus and related diseases 3
-
- Cholinesterase and Neurodegenerative Diseases 2
-
- Monoclonal and Polyclonal Antibodies Research 2
Robert Glanzman
14 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Pathology and Forensic Medicine 529
- Neurology 354
- Immunology 292
- Anesthesiology and Pain Medicine 69
- Physiology 221
Countries citing papers authored by Robert Glanzman
This map shows the geographic impact of Robert Glanzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Glanzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Glanzman more than expected).
Fields of papers citing papers by Robert Glanzman
This network shows the impact of papers produced by Robert Glanzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Glanzman. The network helps show where Robert Glanzman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Glanzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 30 | |
| 2 | 2021 | 33 | |
| 3 | 2021 | 25 | |
| 4 | 2017 | 4 | |
| 5 | 2016 | 12 | |
| 6 | 2012 | 1 | |
| 7 | 2012 | 2 | |
| 8 | 2012 | 1 | |
| 9 | 2012 | 1 | |
| 10 | 2012 | 15 | |
| 11 | Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialbreakdown → | 2011 | 538 |
| 12 | 2007 | 76 | |
| 13 | 2003 | 300 | |
| 14 | 1990 | 29 |
About Robert Glanzman
Robert Glanzman is a scholar working on Neurology, Pathology and Forensic Medicine, Anesthesiology and Pain Medicine, Oncology and Rheumatology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (6 papers), Polyomavirus and related diseases (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers), Peripheral Neuropathies and Disorders (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (529 citations), Neurology (354 citations), Immunology (292 citations), Anesthesiology and Pain Medicine (69 citations) and Physiology (221 citations). Robert Glanzman has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Miroslav Bačkonja, David Leppert, David Li, Frederik Barkhof, Stephen L. Hauser, Peter A. Calabresi, Ludwig Kappos, Ming Yin, Paul O’Connor and Amit Bar‐Or. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, The Lancet, Muscle & Nerve and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.